Difference between revisions of "Induced pluripotent stem cells"
(tie in with broader term) |
(saving progress, currently expanding article) |
||
| Line 1: | Line 1: | ||
| − | '''Induced pluripotent stem cells''' | + | '''Induced pluripotent stem cells''', also known as '''iPSCs''', are pluripotent [[stem cells]] derived from [[cell differentiation|fully-differentiated]] ("adult") somatic cells. While they are often mistakenly referred to as "[[adult stem cells]]", this is not the proper term for them because biologists more commonly use the phrase "adult stem cells" to refer to the partially-differentiated stem cells residing in somatic tissues. |
| − | + | ||
| + | iPSCs are generated by [[transfection|transfecting]] fully differentiated cells with a combination of [[transcription factors]] that cause the cells to de-differentiate into a pluripotent state, mimicking the pluripotency of [[embryonic stem cells]]. As pluripotent cells, iPSCs can generate cells of any type; they can even be used to generate "organoids" (structures mimicking the organization of complex tissues) in-vitro (in [[cell culture|culture]]). | ||
| + | |||
| + | Current methods of generating iPSCs are not without limitations. While the process of inducing de-differentiation does yield pluripotent cells, these cells retain some [[epigenetics|epigenitic]] imprinting of the cell type from which they were derived. As such, iPSCs do not perfectly recapitulate the behavior of embryonic stem cells. Additionally, cell transplantation studies have demonstrated that iPSCs are significantly (~3-4 times, depending on the source tissue and method of induction) more tumorigenic in-vivo than embryonic stem cells, limiting their current therapeutic potential. | ||
==References== | ==References== | ||
Revision as of 01:10, October 10, 2012
Induced pluripotent stem cells, also known as iPSCs, are pluripotent stem cells derived from fully-differentiated ("adult") somatic cells. While they are often mistakenly referred to as "adult stem cells", this is not the proper term for them because biologists more commonly use the phrase "adult stem cells" to refer to the partially-differentiated stem cells residing in somatic tissues.
iPSCs are generated by transfecting fully differentiated cells with a combination of transcription factors that cause the cells to de-differentiate into a pluripotent state, mimicking the pluripotency of embryonic stem cells. As pluripotent cells, iPSCs can generate cells of any type; they can even be used to generate "organoids" (structures mimicking the organization of complex tissues) in-vitro (in culture).
Current methods of generating iPSCs are not without limitations. While the process of inducing de-differentiation does yield pluripotent cells, these cells retain some epigenitic imprinting of the cell type from which they were derived. As such, iPSCs do not perfectly recapitulate the behavior of embryonic stem cells. Additionally, cell transplantation studies have demonstrated that iPSCs are significantly (~3-4 times, depending on the source tissue and method of induction) more tumorigenic in-vivo than embryonic stem cells, limiting their current therapeutic potential.
References
- Yu, J. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science. November 20, 2007.